This research develops a PET material coated with nature-inspired nano-spikes that kill bacteria on contact. By preventing infections on medical devices, the technology can reduce antibiotic use and slow the rise of superbugs. The nano-spikes puncture bacterial cell walls, stopping movement, division, and ultimately causing cell rupture.

This research tests a new personalised care model for Parkinson’s called Prime Care, offering rapid access to support and tailored interventions based on each patient’s risk of hospital admission. A two-year clinical trial of 214 participants will determine whether this approach improves wellbeing and reduces costly, harmful hospital stays.